Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell H Crawford

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Hepatology (Baltimore, Md.)|August 5, 2015
Reply: To PMID 25524401Leon A Adams, Darrell H Crawford, Tim K St Pierre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2015
Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, AustraliaPaul J Clark, Katherine A Stuart, Barbara A Leggett, et al.
Annals of Hepatology|December 17, 2009
Altered clot kinetics in patients with non-alcoholic fatty liver diseaseIngrid J Hickman, Clair M Sullivan, Simone Flight, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1William Sievert, Gregory J Dore, Geoffrey W McCaughan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 21, 2021
ReplyJanske Reiling, Nick Butler, Andrew H Simpson, et al.
Archives of Internal Medicine|February 16, 2006
Screening for hemochromatosis in asymptomatic subjects with or without a family historyLawrie W Powell, Jeannette L Dixon, Grant A Ramm, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Hepatology (Baltimore, Md.)|December 20, 2014
The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trialLeon A Adams, Darrell H Crawford, Katherine Stuart, et al.
Hepatology International|March 20, 2015
Reimbursement policies in the Asia-Pacific for chronic hepatitis BSeng Gee Lim, Deepak N Amarapurkar, Henry Lik-Yuen Chan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|August 5, 2015
Reply: To PMID 25524401Leon A Adams, Darrell H Crawford, Tim K St Pierre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2015
Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, AustraliaPaul J Clark, Katherine A Stuart, Barbara A Leggett, et al.
Annals of Hepatology|December 17, 2009
Altered clot kinetics in patients with non-alcoholic fatty liver diseaseIngrid J Hickman, Clair M Sullivan, Simone Flight, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1William Sievert, Gregory J Dore, Geoffrey W McCaughan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 21, 2021
ReplyJanske Reiling, Nick Butler, Andrew H Simpson, et al.
Archives of Internal Medicine|February 16, 2006
Screening for hemochromatosis in asymptomatic subjects with or without a family historyLawrie W Powell, Jeannette L Dixon, Grant A Ramm, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Hepatology (Baltimore, Md.)|December 20, 2014
The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trialLeon A Adams, Darrell H Crawford, Katherine Stuart, et al.
Hepatology International|March 20, 2015
Reimbursement policies in the Asia-Pacific for chronic hepatitis BSeng Gee Lim, Deepak N Amarapurkar, Henry Lik-Yuen Chan, et al.
Pageof 1